The Impact of African Ancestry on Prostate Cancer Disparities in the Era of Precision Medicine

被引:24
|
作者
Lewis, Deyana D. [1 ]
Cropp, Cheryl D. [2 ]
机构
[1] NHGRI, Computat & Stat Genom Branch, Baltimore, MD 21224 USA
[2] Samford Univ, Dept Pharmaceut Social & Adm Sci, McWhorter Sch Pharm, Birmingham, AL 35229 USA
基金
美国国家卫生研究院;
关键词
prostate cancer; genetics; health disparity; African ancestry; clinical trials; GENOME-WIDE ASSOCIATION; ANDROGEN RECEPTOR GENE; BRCA2 MUTATION CARRIERS; CAG REPEAT LENGTH; 8Q24 RISK ALLELES; AMERICAN MEN; SOCIOECONOMIC-STATUS; CYP17; GENE; SUSCEPTIBILITY LOCUS; CLINICAL-TRIALS;
D O I
10.3390/genes11121471
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Prostate cancer disproportionately affects men of African ancestry at nearly twice the rate of men of European ancestry despite the advancement of treatment strategies and prevention. In this review, we discuss the underlying causes of these disparities including genetics, environmental/behavioral, and social determinants of health while highlighting the implications and challenges that contribute to the stark underrepresentation of men of African ancestry in clinical trials and genetic research studies. Reducing prostate cancer disparities through the development of personalized medicine approaches based on genetics will require a holistic understanding of the complex interplay of non-genetic factors that disproportionately exacerbate the observed disparity between men of African and European ancestries.
引用
收藏
页码:1 / 28
页数:28
相关论文
共 50 条
  • [41] Integrative cancer genomics in the era of precision cancer medicine
    Inazawa, Johji
    Miki, Yoshio
    Nakamura, Yusuke
    JOURNAL OF HUMAN GENETICS, 2021, 66 (09) : 843 - 843
  • [42] Breast cancer screening in the precision medicine era
    Thompson, C. K.
    Fiscalini, A. S.
    Donnellan, P.
    Kaplan, C. P.
    Madlensky, L.
    Eklund, M.
    Ziv, E.
    van't Veer, L. J.
    Tice, J. A.
    Esserman, L. J.
    CANCER RESEARCH, 2016, 76
  • [43] Editorial: Cancer genomics in the era of precision medicine
    Khan, Omar M.
    Mallardo, Domenico
    Decock, Julie
    FRONTIERS IN GENETICS, 2024, 15
  • [44] Orphan Cancer Drugs in the Era of Precision Medicine
    Nabhan, Chadi
    Phillips, Eli G., Jr.
    Feinberg, Bruce A.
    JAMA ONCOLOGY, 2018, 4 (11) : 1481 - 1482
  • [45] Gastrointestinal cancer research in the era of precision medicine
    Lin Shen
    OncologyandTranslationalMedicine, 2017, 3 (01) : 1 - 2
  • [46] Personalised cancer care in the era of precision medicine
    Koczwara, Bogda
    Thornton-Benko, Elysia
    Cohn, Richard J.
    Chan, Raymond J.
    Rhee, Joel
    Joske, David
    Iddawela, Mahesh
    Vardy, Janette L.
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2021, 50 (08) : 533 - 537
  • [47] Cell death in cancer in the era of precision medicine
    Giuseppe Raschellà
    Gerry Melino
    Alessandra Gambacurta
    Genes & Immunity, 2019, 20 : 529 - 538
  • [48] Cell death in cancer in the era of precision medicine
    Raschella, Giuseppe
    Melino, Gerry
    Gambacurta, Alessandra
    GENES AND IMMUNITY, 2019, 20 (07) : 529 - 538
  • [49] Breast Cancer Prevention in the Era of Precision Medicine
    Narod, Steven A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (05):
  • [50] Implementing precision cancer medicine in the genomic era
    Chen, Hui-Zi
    Bonneville, Russell
    Roychowdhury, Sameek
    SEMINARS IN CANCER BIOLOGY, 2019, 55 : 16 - 27